The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monoclonal Antibodies Market Research Report 2024
Synopsis
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
The global Monoclonal Antibodies market was valued at US$ 105790 million in 2023 and is anticipated to reach US$ 144360 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies.
Report Scope
The Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Segment by Type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Segment by Application
Anti-Cancer
Anti-Inflammatory/Autoimmune
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
The global Monoclonal Antibodies market was valued at US$ 105790 million in 2023 and is anticipated to reach US$ 144360 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies.
Report Scope
The Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Segment by Type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Segment by Application
Anti-Cancer
Anti-Inflammatory/Autoimmune
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Monoclonal Antibodies
1.2 Monoclonal Antibodies Segment by Type
1.2.1 Global Monoclonal Antibodies Market Value Comparison by Type (2024-2030)
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Monoclonal Antibodies Segment by Application
1.3.1 Global Monoclonal Antibodies Market Value by Application: (2024-2030)
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Global Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Monoclonal Antibodies Revenue 2019-2030
1.4.2 Global Monoclonal Antibodies Sales 2019-2030
1.4.3 Global Monoclonal Antibodies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2019-2024)
2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2019-2024)
2.4 Global Monoclonal Antibodies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monoclonal Antibodies, Product Type & Application
2.7 Monoclonal Antibodies Market Competitive Situation and Trends
2.7.1 Monoclonal Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monoclonal Antibodies Players Market Share by Revenue
2.7.3 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Monoclonal Antibodies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Monoclonal Antibodies Global Monoclonal Antibodies Sales by Region: 2019-2030
3.2.1 Global Monoclonal Antibodies Sales by Region: 2019-2024
3.2.2 Global Monoclonal Antibodies Sales by Region: 2025-2030
3.3 Global Monoclonal Antibodies Global Monoclonal Antibodies Revenue by Region: 2019-2030
3.3.1 Global Monoclonal Antibodies Revenue by Region: 2019-2024
3.3.2 Global Monoclonal Antibodies Revenue by Region: 2025-2030
3.4 North America Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 North America Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Monoclonal Antibodies Sales by Country (2019-2030)
3.4.3 North America Monoclonal Antibodies Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Monoclonal Antibodies Market Facts & Figures by Country
3.5.1 Europe Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Monoclonal Antibodies Sales by Country (2019-2030)
3.5.3 Europe Monoclonal Antibodies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Monoclonal Antibodies Sales by Country (2019-2030)
3.6.3 Asia Pacific Monoclonal Antibodies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Latin America Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Monoclonal Antibodies Sales by Country (2019-2030)
3.7.3 Latin America Monoclonal Antibodies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Monoclonal Antibodies Sales by Country (2019-2030)
3.8.3 Middle East and Africa Monoclonal Antibodies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Monoclonal Antibodies Sales by Type (2019-2030)
4.1.1 Global Monoclonal Antibodies Sales by Type (2019-2024)
4.1.2 Global Monoclonal Antibodies Sales by Type (2025-2030)
4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2019-2030)
4.2 Global Monoclonal Antibodies Revenue by Type (2019-2030)
4.2.1 Global Monoclonal Antibodies Revenue by Type (2019-2024)
4.2.2 Global Monoclonal Antibodies Revenue by Type (2025-2030)
4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2019-2030)
4.3 Global Monoclonal Antibodies Price by Type (2019-2030)
5 Segment by Application
5.1 Global Monoclonal Antibodies Sales by Application (2019-2030)
5.1.1 Global Monoclonal Antibodies Sales by Application (2019-2024)
5.1.2 Global Monoclonal Antibodies Sales by Application (2025-2030)
5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2019-2030)
5.2 Global Monoclonal Antibodies Revenue by Application (2019-2030)
5.2.1 Global Monoclonal Antibodies Revenue by Application (2019-2024)
5.2.2 Global Monoclonal Antibodies Revenue by Application (2025-2030)
5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2019-2030)
5.3 Global Monoclonal Antibodies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biocon
6.1.1 Biocon Corporation Information
6.1.2 Biocon Description and Business Overview
6.1.3 Biocon Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biocon Monoclonal Antibodies Product Portfolio
6.1.5 Biocon Recent Developments/Updates
6.2 Celltrion
6.2.1 Celltrion Corporation Information
6.2.2 Celltrion Description and Business Overview
6.2.3 Celltrion Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celltrion Monoclonal Antibodies Product Portfolio
6.2.5 Celltrion Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Hospira
6.4.1 Hospira Corporation Information
6.4.2 Hospira Description and Business Overview
6.4.3 Hospira Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hospira Monoclonal Antibodies Product Portfolio
6.4.5 Hospira Recent Developments/Updates
6.5 3SBio
6.5.1 3SBio Corporation Information
6.5.2 3SBio Description and Business Overview
6.5.3 3SBio Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 3SBio Monoclonal Antibodies Product Portfolio
6.5.5 3SBio Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Accord Healthcare Monoclonal Antibodies Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 AET Biotech
6.6.1 AET Biotech Corporation Information
6.6.2 AET Biotech Description and Business Overview
6.6.3 AET Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AET Biotech Monoclonal Antibodies Product Portfolio
6.7.5 AET Biotech Recent Developments/Updates
6.8 Allergan
6.8.1 Allergan Corporation Information
6.8.2 Allergan Description and Business Overview
6.8.3 Allergan Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Allergan Monoclonal Antibodies Product Portfolio
6.8.5 Allergan Recent Developments/Updates
6.9 Amega Biotech
6.9.1 Amega Biotech Corporation Information
6.9.2 Amega Biotech Description and Business Overview
6.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Amega Biotech Monoclonal Antibodies Product Portfolio
6.9.5 Amega Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monoclonal Antibodies Industry Chain Analysis
7.2 Monoclonal Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monoclonal Antibodies Production Mode & Process
7.4 Monoclonal Antibodies Sales and Marketing
7.4.1 Monoclonal Antibodies Sales Channels
7.4.2 Monoclonal Antibodies Distributors
7.5 Monoclonal Antibodies Customers
8 Monoclonal Antibodies Market Dynamics
8.1 Monoclonal Antibodies Industry Trends
8.2 Monoclonal Antibodies Market Drivers
8.3 Monoclonal Antibodies Market Challenges
8.4 Monoclonal Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
